NEAT1 and cancer: A contribution of NEAT1 to cancer progression has recently been investigated in the following cancer types as well, that is, gastric cancer (Tan et al., 2018), osteosarcoma (Hu et al., 2018; Wang et al., 2017a), glioblastoma (Gong et al., 2016; Yang et al., 2017b), oral and esophageal carcinoma (Huang et al., 2018; Li et al., 2017a), clear cell renal carcinoma (Liu et al., 2017), and cervical carcinoma (Han et al., 2018; Wang and Zhu, 2018).